Ryanodine receptor antagonist

This page covers all Ryanodine receptor antagonist drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Ryanodine receptor (RyR1).

Targets

Ryanodine receptor (RyR1)

Phase 3 pipeline (1)

• Ryanodex and Standard of Care · Eagle Pharmaceuticals, Inc. · Anesthesiology / Critical Care
  Ryanodex is a dantrolene sodium formulation that blocks calcium release from the sarcoplasmic reticulum in skeletal muscle by inhibiting the ryanodine receptor.

Patent intelligence

• ryanodine receptor antagonist patent landscape — aggregated cliff calendar, attackable patents, originator estates